
Watermelon
Wet fruit. Loud green.
€12.99 · 15 pouches
Also in Mini 59 mm x 21 mm · 9 pouches
Kanna. The Happy Plant. A botanical oral pouch — nicotine free, tobacco free, made for people who read the back of the tin.
Most pouches hide what they are. KNA is built the other way around — a botanical from Southern Africa, a formulation we document, and a design language we do not apologise for.


Kanna is the common name for Sceletium tortuosum, a succulent plant native to the arid regions of Southern Africa. It has a long documented history of traditional use in southern Africa, and it is the botanical at the centre of KNA.
We describe the plant, its origin and how we prepare it — and nothing further. KNA makes no medical or therapeutic claim, and does not state what kanna does to you. Where data is not yet published, we say so plainly.

We work with a mesembrine-type alkaloid extract rather than raw plant material, so every pouch in a batch carries the same botanical input instead of whatever the harvest gave us.

A pouch sits under the lip against thin, well-supplied oral tissue. Compounds cross there directly, so they are not first broken down in the stomach and liver the way a swallowed capsule is.

Saliva releases the extract within seconds, and a pH regulator keeps the pouch in the range where the alkaloids stay in their more readily absorbed form.
This describes how the pouch is made and how oral delivery works. We publish no onset times, absorption percentages or effect claims until our own batch data is measured and reviewed.

A low, fleshy succulent of arid Southern Africa — leaves that store water against the dry season.
Know what's inside. We publish what is confirmed and label what is not. No effect claims, no invented numbers, no borrowed certificates.
Sceletium tortuosum, sourced from South Africa. We document the plant material used in each production run.
DocumentedPer-pouch composition will be published once confirmed by the manufacturer.
Formulation data coming soonThird-party analytical documentation is attached to each batch as it becomes available.
Document pendingQuantities per pouch are not stated until confirmed by the manufacturer. No effect claims are made.
Kanna has been studied for decades. Here is what that research actually describes — the targets, the signalling, and the limits of the evidence. None of this is a claim about what a KNA pouch will do for you.
Kanna's activity is attributed to a group of mesembrine-type alkaloids — mesembrine, mesembrenone, mesembrenol and mesembranol. Their ratio varies with plant material and processing, which is why the raw material used in each run is documented.
In laboratory assays mesembrine is a potent inhibitor of the serotonin transporter (SERT), the protein that clears serotonin back out of the synapse. Inhibiting it means released serotonin lingers longer at the receptor — the same target class that conventional SSRIs act on, though studied here only in vitro and at very different exposures.
Mesembrenone acts on a second target: phosphodiesterase-4 (PDE4), the enzyme that breaks down cyclic AMP inside neurons. Less breakdown means cAMP second-messenger signalling persists longer. This dual SERT/PDE4 profile is what distinguishes kanna pharmacologically from a single-target reuptake inhibitor.
A randomised, placebo-controlled fMRI study of a standardised Sceletium tortuosum extract (Terburg et al., Neuropsychopharmacology, 2013) reported reduced amygdala reactivity to fearful faces and weaker amygdala–hypothalamus coupling after a single dose. The amygdala is central to threat appraisal; that circuit is the most direct human evidence available.
An oral pouch sits against the gum, so plant constituents meet the buccal mucosa rather than passing first through the stomach. Comparative absorption data for the pouch format has not been published, and KNA does not estimate it.
Most mechanism work on kanna is laboratory work — isolated enzymes and transporters, not people. Human trials to date are small, short and run on standardised extracts, not on pouches. Because mesembrine-type alkaloids act on serotonin handling, kanna should not be combined with SSRIs, SNRIs, MAOIs or other serotonergic medication without medical advice. KNA is not intended to diagnose, treat, cure or prevent any disease.
Each flavour is its own world — colour, light and motion shift with it. Hover a tin to step inside.
Two tin sizes — Standard 70 mm x 21 mm with 15 pouches, or Mini 59 mm x 21 mm with 9 pouches. Nicotine free, tobacco free. Add to cart and check out in seconds.
Distributors, wholesalers and retail groups — master cases of 240 tins, shipping from our USA and Europe warehouses, with a 50% retail and 25% distributor margin built in.